Insider Stock Trading History of Shacham Sharon


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shacham Sharon since year 2005. The trader's CIK number is 1588438. At the time of this reporting, Shacham Sharon is the President & CSO of Karyopharm Therapeutics Inc. . (stock ticker symbol KPTI). See this page for all insider trading activities at Karyopharm Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Shacham Sharon since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-10-08 KPTI Karyopharm Therapeutics Inc. Option Ex 12,500 .03 412
2018-10-08 KPTI Karyopharm Therapeutics Inc. Sale 12,500 15.76 197,012
2018-09-18 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 4.75 47,520
2018-09-18 KPTI Karyopharm Therapeutics Inc. Sale 10,000 18.26 182,620
2018-09-07 KPTI Karyopharm Therapeutics Inc. Sale 12,500 19.31 241,387
2018-09-07 KPTI Karyopharm Therapeutics Inc. Option Ex 12,500 .03 412
2018-08-20 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 4.75 47,520
2018-08-20 KPTI Karyopharm Therapeutics Inc. Sale 10,000 17.46 174,570
2018-08-07 KPTI Karyopharm Therapeutics Inc. Option Ex 12,500 .03 412
2018-08-07 KPTI Karyopharm Therapeutics Inc. Sale 12,500 18.05 225,562
2018-07-18 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 1.68 16,830
2018-07-18 KPTI Karyopharm Therapeutics Inc. Sale 10,000 18.27 182,689
2018-07-09 KPTI Karyopharm Therapeutics Inc. Sale 12,500 18.72 233,987
2018-07-09 KPTI Karyopharm Therapeutics Inc. Option Ex 12,500 .03 412
2018-06-18 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-06-18 KPTI Karyopharm Therapeutics Inc. Sale 10,000 18.66 186,560
2018-06-07 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .15 1,490
2018-06-07 KPTI Karyopharm Therapeutics Inc. Sale 10,000 17.30 172,990
2018-05-18 KPTI Karyopharm Therapeutics Inc. Sale 10,000 19.39 193,870
2018-05-18 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-05-07 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-05-07 KPTI Karyopharm Therapeutics Inc. Sale 10,000 16.77 167,750
2018-04-18 KPTI Karyopharm Therapeutics Inc. Sale 10,000 14.79 147,880
2018-04-18 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-04-09 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-04-09 KPTI Karyopharm Therapeutics Inc. Sale 10,000 12.48 124,830
2018-03-19 KPTI Karyopharm Therapeutics Inc. Sale 10,000 15.29 152,900
2018-03-19 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-03-07 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-03-07 KPTI Karyopharm Therapeutics Inc. Sale 10,000 16.15 161,460
2018-02-20 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-02-20 KPTI Karyopharm Therapeutics Inc. Sale 10,000 14.79 147,870
2018-02-07 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-02-07 KPTI Karyopharm Therapeutics Inc. Sale 10,000 12.51 125,050
2018-01-18 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-01-18 KPTI Karyopharm Therapeutics Inc. Sale 10,000 10.09 100,879
2018-01-08 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2018-01-08 KPTI Karyopharm Therapeutics Inc. Sale 10,000 10.08 100,770
2017-12-18 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2017-12-18 KPTI Karyopharm Therapeutics Inc. Sale 10,000 9.15 91,550
2017-12-07 KPTI Karyopharm Therapeutics Inc. Sale 10,000 10.39 103,900
2017-12-07 KPTI Karyopharm Therapeutics Inc. Option Ex 10,000 .26 2,640
2015-01-12 KPTI Karyopharm Therapeutics Inc. Sale 50,000 33.00 1,650,000
2014-07-02 KPTI Karyopharm Therapeutics Inc. Sale 200,000 42.50 8,500,000
2014-06-17 KPTI Karyopharm Therapeutics Inc. Sale 10,000 40.36 403,640
2014-06-18 KPTI Karyopharm Therapeutics Inc. Sale 10,000 43.15 431,520

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shacham Sharon (President & CSO of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.